Comprehensively reviews significant UK court decisions and practice directions, IP Office decisions and EPO Appeal Board decisions up to 30 September 2018.
Outlines UK, EPO and US decisions on eligibility, including the recent US CAFC decision in Berkheimer v HP Inc and its implications for UK practitioners.
Reviews Actavis v Icos on “obvious to try”, expected to be heard in the Supreme Court in November 2018, and reviews other significant cases on inventive step.
Will hopefully discuss the Supreme Court plausibility decision in Warner-Lambert v Generics, expected availability October 2018.
Discusses disclaimers in the light of EPO Enlarged Appeal Board decision G 1/16.
Updates the on-going significance of the Supreme Court decision in Actavis.
Reviews the likely impact of Brexit on SPCs and summarises recent case law.
Outlines recent patent licence decisions, e.g. in relation to FRAND licenses.
Summarises a recent Disciplinary Rules decision on provision of terms of business.
.jpg?1680780797)
